A Phase 1, Bioavailability Study of Relatlimab in Combination With Nivolumab

NCT04112498 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Cancer

Interventions

DRUG: relatlimab
DRUG: nivolumab
DRUG: rHuPH20

Sponsor

Bristol-Myers Squibb